Golden has been acquired by ComplyAdvantage.Read about it here ⟶

SalioGen Therapeutics

SalioGen Therapeutics is a gene Therapy Platform Technology.

Overview Structured Data Issues Contributors Activity

saliogen.com

Is a

Organization

Company

Company attributes

Industry

Biomedical engineering

Engineering

Biotechnology

Location

Burlington, Massachusetts

Cambridge, Massachusetts

United States

Pitchbook URL

pitchbook.com/profiles...460323-10

Email Address

investors@saliogen.com0

info@saliogen.com0

media@saliogen.com0

jobs@saliogen.com0

Phone Number

+185799022000

Full Address

245 First Street, 18th Floor, Cambridge, MA 02142, USA0

Investors

Fidelity Investments

Cystic Fibrosis Foundation

D1 Capital Partners

PBM Capital

EPIQ Capital Group

Total Funding Amount (USD)

115,000,000

Latest Funding Round Date

January 5, 2022

Latest Funding Type

Series B Round

Country

United States

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

115,000,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like SalioGen Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API